DK143335B - ANALOGY PROCEDURE FOR PREPARING BIS (5-MERCAPTOPYRIDOXIN) -ETHAN-1,2-DISULPHONATE - Google Patents
ANALOGY PROCEDURE FOR PREPARING BIS (5-MERCAPTOPYRIDOXIN) -ETHAN-1,2-DISULPHONATE Download PDFInfo
- Publication number
- DK143335B DK143335B DK179376AA DK179376A DK143335B DK 143335 B DK143335 B DK 143335B DK 179376A A DK179376A A DK 179376AA DK 179376 A DK179376 A DK 179376A DK 143335 B DK143335 B DK 143335B
- Authority
- DK
- Denmark
- Prior art keywords
- bis
- ethane
- salt
- methyl
- mercaptopyridoxin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
(19) DANMARK (®£(19) DENMARK (® £
© (12) FREMLÆGGELSESSKRIFT ud 11*3335 B© (12) PUBLICATION OUT 11 * 3335 B
DIREKTORATET FOR PATENT-OG VAREMÆRKEVÆSENETPATENT AND TRADEMARKET DIRECTORATE
(21) Ansøgning nr. 1793/76 (51) IntCI.3 C 07 D 213/66 (22) Indløveringsdag 21. apr. 1976 (24) Løbedag 21 . apr. 1976 (41) Aim. tilgængelig 10. nov. 1976 (44) Fremlagt 10. aug. 1981 (86) International ansøgning nr. - (86) International indleveringsdag - (85) Videreførelsesdag - (62) Stamansøgning nr. -(21) Application No. 1793/76 (51) IntCI.3 C 07 D 213/66 (22) Commencement date 21 Apr. 1976 (24) Race day 21. April 1976 (41) Aim. available Nov. 10; 1976 (44) Presented Aug. 10; 1981 (86) International Application No. - (86) International Filing Day - (85) Continuation Day - (62) Master Application No. -
(30) Prioritet 9. maj 1975# 5760 55, US(30) Priority May 9, 1975 # 5760 55, US
(71) Ansøger MERCK & CO. INC., Rahway, US.(71) Applicant MERCK & CO. INC., Rahway, US.
(72) Opfinder Conrad Peter Dorn, US: Howard Jones, US: David(72) Inventor Conrad Peter Dorn, US: Howard Jones, US: David
Penman Jacobus, US.Penman Jacobus, US.
(74) Fuldmægtig Ingeniørfirmaet Hofman-Bang & Bout ard.(74) Associate Engineer Hofman-Bang & Bout ard.
(54) Analogifremgangsmåde til frem= stilling af bis(5-mercaptopyri= dcxin)-ethan-1,2-disulfonat.(54) Analogous process for the preparation of bis (5-mercaptopyric = dxxin) -ethane-1,2-disulfonate.
Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af bis(5-mercaptopyridoxin)-ethan-l,2-disulfonat med den i kravet angivne formel, hvilken fremgangsmåde er ejendommelig ved det i kravets kendetegnende del angivne. Det farmaceutisk acceptable salt er en fysisk, kemisk og farmaceutisk forbedret form for det kendte farmakologisk aktive 2-methyl-3-hydroxy-4-•j hydroxymethyl-5-mercaptomethylpyridin-(5-mercaptopyridoxin eller > 5-MP).The present invention relates to an analogous process for the preparation of bis (5-mercaptopyridoxine) -ethane-1,2-disulfonate of the formula set forth in the claim which is characterized by the characterizing part of the claim. The pharmaceutically acceptable salt is a physical, chemically and pharmaceutically improved form of the known pharmacologically active 2-methyl-3-hydroxy-4- (hydroxymethyl-5-mercaptomethylpyridine- (5-mercaptopyridoxine or> 5-MP)).
) 5 Den ved fremgangsmåden ifølge opfindelsen fremstillede forbindel- [ se er egnet til behandling af rheumatisk arthritis.The compound prepared by the process of the invention is suitable for the treatment of rheumatic arthritis.
* » i 2 143335* »I 2 143335
Forbindelsen 5-mercaptopyridoxin er rapporteret som farmakologisk aktiv som et strålingsbeskyttende middel, og som et anti-rheuma-tisk arthritisk middel, der fortrinvis anvendes i form af et salt med en farmaceutisk acceptabel syre (DE-OS 2 428 031). Foretrukne salte er hydrochlorid og hydrobromid.The compound 5-mercaptopyridoxine is reported as pharmacologically active as a radiation protection agent and as an anti-rheumatic arthritic agent, preferably used in the form of a salt with a pharmaceutically acceptable acid (DE-OS 2 428 031). Preferred salts are hydrochloride and hydrobromide.
Det har vist sig, at de hidtil kendte salte, som er nævnt i litteraturen, især hydrochloridet, lider af alvorlige fysiske, kemiske og/eller farmaceutiske ulemper som følge af deres kemiske instabilitet eller på grund af andre uønskede egenskaber. Det har nu overraskende vist sig, at ethan-l,2-disulfonatsaltet (edisylat) af 5-mercaptopyridoxin er i hovedsagen fri for denne ulempe og derfor mere velegnet end de hidtil foretrukne salte som bestanddel af farmaceutiske enhedsdoser. Den forøgede kemiske stabilitet af det omhandlede salt er bekræftet ved aktuelle sammenlignende prøver.It has been found that the known salts mentioned in the literature, especially the hydrochloride, suffer from serious physical, chemical and / or pharmaceutical disadvantages due to their chemical instability or due to other undesirable properties. It has now surprisingly been found that the ethane-1,2-disulfonate salt (edisylate) of 5-mercaptopyridoxine is substantially free of this disadvantage and therefore more suitable than the hitherto preferred salts as a component of pharmaceutical unit doses. The increased chemical stability of the salt in question is confirmed by current comparative tests.
For at vurdere den relative stabilitet af forskellige salte af 5-mercaptopyridoxin blev forsøgssaltene udvalgt (d.v.s. ethan- 1,2-disulfonat, phosphatet, sulfamatet, nitratet og hydrochloridet) og underkastet acclererede betingelser i form af høj temperatur, idet saltene blev benyttet i ren tilstand. Temperaturer på 80°C og 105°C anvendes hensigtsmæssigt for at undersøge forbindelserne på så kort tid som muligt. Hvis et stort antal derivater eller salte er tilgængelige, kan sammenlignelige data opnås, og prøveforbindelserne kan opstilles i en forventet rækkefølge for stabilitet. De termisk påvirkede salte blev undersøgt colorimetrisk for uforandrede thiolgrupper. Ethandisulfonatet, hydrochloridet og sulfamatet blev også underkastet NMR-analyse for at bekræfte de kemiske analyser. De opnåede MR-data understøtter de kemiske data. De opnåede data er i akkumuleret form vist i efterfølgende tabel 1.To assess the relative stability of various salts of 5-mercaptopyridoxine, the test salts were selected (i.e., ethane-1,2-disulfonate, phosphate, sulfamate, nitrate and hydrochloride) and subjected to high temperature accelerated conditions using the salts condition. Temperatures of 80 ° C and 105 ° C are conveniently used to examine the compounds in as short a time as possible. If a large number of derivatives or salts are available, comparable data can be obtained and the test compounds can be prepared in an expected order of stability. The thermally affected salts were colorimetrically examined for unchanged thiol groups. The ethane disulfonate, hydrochloride and sulfamate were also subjected to NMR analysis to confirm the chemical analyzes. The obtained MRI data support the chemical data. The data obtained are in accumulated form shown in subsequent Table 1.
3 1433353 143335
Tabel 1Table 1
Sammenligning af termisk stabilitet af 5-MP-salteComparison of thermal stability of 5-MP salts
Termisk stabilitet % tilbageværende Salt af 5-MP 105°C 80° CThermal stability% residual Salt of 5-MP 105 ° C 80 ° C
|5 dage 7 dage 1 uge 3 uger| 5 days 7 days 1 week 3 weeks
Ethandisulfonat 97,3 99,4 101,0 100,2Ethanedisulfonate 97.3 99.4 101.0 100.2
Hydrochlorid 57,3 — 70,5 57,3Hydrochloride 57.3 - 70.5 57.3
Sulfamat 13,0 8,8 94,0 75,7Sulfamate 13.0 8.8 94.0 75.7
Phosphat 93,0 58,0Phosphate 93.0 58.0
Nitrat — — 87,2 III ' " ------1 ..... I * ' Ί i 1 " . "'1'Nitrate - - 87.2 III '"------ 1 ..... I *' Ί i 1". " '1'
Disse data viser klart, at ethandisulfonatsaltet er det mest stabile salt ved de anvendte temperaturer. Af disse data fremgår det, at ethandisulfonatsaltet er det foretrukne.These data clearly show that the ethanedisulfonate salt is the most stable salt at the temperatures used. From these data it appears that the ethanedisulfonate salt is the preferred one.
Fremgangsmåden ifølge opfindelsen kan udføres ved, at man blander 2 molære dele 5-mercaptopyridoxin eller et opløseligt syreadditionssalt deraf, fortrinsvis hydrochloridet, og 1 molær del ethandisulf onsyre eller et alkalimetal- eller jordalkalimetalsalt deraf, fortrinsvis natriumsaltet, i et flydende medium, der i nogen grad kan opløse de to udgangsmaterialer, ved en temperatur mellem stuetemperatur og kogetemperaturen. Produktet isoleres ved krystallisation af et flydende medium ved afkøling og/eller om fornødent ved koncentration. Ifølge en foretrukken udførelsesform bliver 5-mercaptopyridoxin-hydrohalogenidet, fortrinsvis hydrochloridet, og et alkalimetal- eller jordalkalimetalsalt af et ethandisulfonat, fortrinsvis natriumsaltet, i det ovenfor angivne molære forhold opløst i en minimal mængde vand ved stuetemperatur og efterfølgende afkøling.The process of the invention can be carried out by mixing 2 molar portions of 5-mercaptopyridoxine or a soluble acid addition salt thereof, preferably the hydrochloride, and 1 molar portion of one-hand disulphonic acid or an alkali metal or alkaline earth metal salt thereof, preferably the sodium salt, in a liquid medium therein. degree can dissolve the two starting materials, at a temperature between room temperature and the boiling temperature. The product is isolated by crystallization of a liquid medium by cooling and / or, if necessary, by concentration. In a preferred embodiment, the 5-mercaptopyridoxine hydrohalide, preferably the hydrochloride, and an alkali metal or alkaline earth metal salt of an ethanedisulfonate, preferably the sodium salt, are dissolved in the above molar ratio in a minimal amount of water at room temperature and subsequently cooled.
' . . 4 143335 I stedet kan den omhandlede hidtil ukendte forbindelse fremstilles ved behandling af bis (2,2,8-trimethyl-4-H-m-dioxino[4,5-c]-pyridyl-5-methyl) disulfid med en blanding af zink- eller tinstøv og ethandisulfonsyre i vand eller et egnet organisk opløsningsmiddel. Reaktionen udføres hensigtsmæssigt ved anbringelse af reaktionsblandingen på dampbad i 1 til 10 timer, fortrinsvis rader en inert atmosfære. Reaktionsblandingen afkøles derefter, filtreres og inddampes i vacuum. Remanensen extraheres i kogende organisk opløsningsmiddel, og filtratet filtreres og afkøles til udfældning af det ønskede salt.'. . Instead, the present novel compound can be prepared by treating bis (2,2,8-trimethyl-4-Hm-dioxino [4,5-c] pyridyl-5-methyl) disulfide with a mixture of zinc or tin dust and ethanedisulfonic acid in water or a suitable organic solvent. The reaction is conveniently carried out by placing the reaction mixture on a steam bath for 1 to 10 hours, preferably an inert atmosphere. The reaction mixture is then cooled, filtered and evaporated in vacuo. The residue is extracted into boiling organic solvent and the filtrate is filtered and cooled to precipitate the desired salt.
Tilsvarende kan den omhandlede hidtil ukendte forbindelse fremstilles ved behandling af bis(2-methyl-3-hydroxy-4-hydroxymethyl-pyridyl-5-methyl)disulfid med en blanding af zink- eller tinstøv og ethandisulfonsyre i vand eller et egnet organisk opløsningsmiddel. Reaktionen udføres som ovenfor beskrevet, og det ønskede salt udvindes på tilsvarende måde.Similarly, the present novel compound can be prepared by treating bis (2-methyl-3-hydroxy-4-hydroxymethyl-pyridyl-5-methyl) disulfide with a mixture of zinc or tin dust and ethanedisulfonic acid in water or a suitable organic solvent. The reaction is carried out as described above and the desired salt is recovered in a similar manner.
Den omhandlede hidtil ukendte forbindelse kan også fremstilles ved behandling af 5-mercaptomethyl-2,2,8-trimethyl-4-H-m-dioxino-[4,5-c]pyridin med ethandisulfonsyre i vand eller et egnet organisk opløsningsmiddel. I dette tilfælde opvarmes reaktionsblandingen . sædvanligvis på dampbad i 2 til 10 timer, fortrinsvis rader en inert atmosfære. Reaktionsblandingen inddampes derefter til opnåelse af det ønskede salt.The present novel compound may also be prepared by treating 5-mercaptomethyl-2,2,8-trimethyl-4-H-m-dioxino- [4,5-c] pyridine with ethanedisulfonic acid in water or a suitable organic solvent. In this case, the reaction mixture is heated. usually in a steam bath for 2 to 10 hours, preferably an inert atmosphere. The reaction mixture is then evaporated to give the desired salt.
Fremgangsmåden ifølge opfindelsen skal i det efterfølgende illustreres nærmere ved hjælp af nogle eksempler.The process according to the invention will be illustrated in the following by way of some examples.
EKSEMPEL- 1EXAMPLE 1
Bis(2-methvl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-•pyridinjuml - ethan-1,2-di sulf onat_Bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinyl) -ethane-1,2-di-sulfonate
En opløsning af 11,1 g (0,05 mol) 5-mercaptopyridoxin-hydro-chlorid i 40 ml vand blandes med en opløsning af 5>85 g (0,025 mol) dinatrium- ethan-l,2-disulfonat i 40 ml vand ved stuetemperatur. Blandingen afkøledes på isbad, indtil udfældningen var fuldstændig. Bundfaldet (1) opsamledes på et filter, og filtratet ind- 5 143336 dampedes til ca. 40 ml og afkøledes atter på isbad, indtil udfældningen var fuldstændig. Bundfaldet (2) opsamledes på et filter, og filtratet inddampedes til ca. 20 ml og afkøledes på isbad, indtil udfældningen var fuldstændig. Bundfaldet (3) opsamledes på et filter. Bundfaldene (1), (2) og (3) forenedes og omkrystalliseredes af methanol til dannelse af 6,5 g bis(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethylpyridinium )-ethan-l,2-disulfonat, smp: 178 - 180°C.A solution of 11.1 g (0.05 mol) of 5-mercaptopyridoxine hydrochloride in 40 ml of water is mixed with a solution of 5> 85 g (0.025 mol) of disodium ethanol 1,2-disulfonate in 40 ml of water. at room temperature. The mixture was cooled in an ice bath until the precipitation was complete. The precipitate (1) was collected on a filter and the filtrate was evaporated to ca. 40 ml and cooled again in an ice bath until the precipitation was complete. The precipitate (2) was collected on a filter and the filtrate was evaporated to ca. 20 ml and cooled in an ice bath until the precipitation was complete. The precipitate (3) was collected on a filter. The precipitates (1), (2) and (3) were combined and recrystallized from methanol to give 6.5 g of bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethylpyridinium) -ethane-1,2-disulfonate mp: 178-180 ° C.
Ved at gentage den i eks. 1 beskrevne fremgangsmåde med den ændring, at der i stedet for dinatrium-ethan-l,2-disulfonat anvendes en ækvimolær mængde di(metal)-ethandisulfonater fås samme syreadditionssalt af 5-mercaptopyridoxin i overensstemmelse med ligning I.By repeating the procedure described in Example 1 with the change that instead of disodium ethanol-1,2-disulfonate an equimolar amount of di (metal) ethanedisulfonates is used, the same acid addition salt of 5-mercaptopyridoxine is obtained in accordance with Equation I .
ch2oh Ligning Ich2oh Equation I
2 H0V^yCH2SH + 0Α CS03M)2 CH3 H®A® ch2oh2 H0V ^ yCH2SH + 0Α CS03M) 2 CH3 H®A® ch2oh
* HCyL^CH2SH* HCyL ^ CH2SH
0¾ (0303),¾¾ 3 H© hvor A O er en syre-anion, og M er en alkalimetal- eller jordalkalimetalion.0¾ (0303), ¾¾ 3 H © where A O is an acid anion and M is an alkali metal or alkaline earth metal ion.
EKSEMPEL 2EXAMPLE 2
Bis(2-methvl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat_Bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium) ethane-1,2-disulfonat_
En blanding af 9,25 g (0,05 m) 5-mercaptopyridoxin, 4,75 g (0,025 m) ethan-1,2-disulfonsyre og 40 ml vand opvarmes, indtil der er dannet en opløsning. Denne afkøles, og bundfaldet fra- 6 143335 filtreres. Ved omkrystallisation af methanol fås bis(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethylpyridinium)-ethan- 1,2-disulfonat, smp. 178 - 180° C.A mixture of 9.25 g (0.05 m) of 5-mercaptopyridoxine, 4.75 g (0.025 m) of ethane-1,2-disulfonic acid and 40 ml of water is heated until a solution is formed. This is cooled and the precipitate is filtered. Recrystallization from methanol gives bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethylpyridinium) -ethane-1,2-disulfonate, m.p. 178 - 180 ° C.
Ligning II forklarer reaktionen nærmere.Equation II explains the reaction in more detail.
Ligning IIEquation II
ch2oh 2 ΗΟγ)γαΗ28Η + C2i^(S03H)2ch2oh 2 ΗΟγ) γαΗ28Η + C2i ^ (SO3H) 2
ch3AJch3AJ
ch2ohCH 2 OH
-> HO^ [ CH-SH-> HO ^ [CH-SH
XT (Θο33,2α2Η4 CH3 H© EKSEMPEL 3XT (33ο33,2α2Η4 CH3 H © EXAMPLE 3
Bis(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-uvridinium) ethan-1.2-disulf onatBis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-urridinium) ethane-1,2-disulfonate
En blanding af 0,1 mol bis(2,2,8-trimethyl-4H-m-dioxino[4,5-c]-pyridyl-5-methyl)disulfid, 0,2 mol zinkstøv, 0,35 mdethan-1,2-disulfonsyre og 200 ml vand opvarmes på dampbad i ca. 5 timer under en nitrogenatomsfære. Reaktionen afkøles, filtreres og inddampes i vacuum. Remanensen extraheres med 100 ml kogende methanol og filtreres, og filtratet afkøles til opnåelse af det ovennævnte produkt, der smelter ved 178 - 180° C.A mixture of 0.1 mole of bis (2,2,8-trimethyl-4H-m-dioxino [4,5-c] pyridyl-5-methyl) disulfide, 0.2 mole of zinc dust, 0.35 mdethane-1 , 2-disulfonic acid and 200 ml of water are heated on a steam bath for approx. 5 hours under a nitrogen atom sphere. The reaction is cooled, filtered and evaporated in vacuo. The residue is extracted with 100 ml of boiling methanol and filtered and the filtrate is cooled to give the above product, which melts at 178 - 180 ° C.
7 143335 EKSEMPEL 4EXAMPLE 4
Bis(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)ethan-1,2-disulfonat_Bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium) ethane-1,2-disulfonat_
En blanding af 0,1 mol 5-mercaptomethyl-2,2,8-trimethyl-4H-m-dioxino[4,5-c]pyridin og 0,055 mol ethan-1,2-disulfonsyre i 100 ml vand opvarmes på dampbad under en atmosfære af nitrogen i ca. 3 timer. Reaktionsblandingen koncentreres til ovennævnte produkt, der smelter ved 178 - 180° C.A mixture of 0.1 mole of 5-mercaptomethyl-2,2,8-trimethyl-4H-m-dioxino [4,5-c] pyridine and 0.055 mole of ethane-1,2-disulfonic acid in 100 ml of water is heated in a steam bath under an atmosphere of nitrogen for approx. 3 hours. The reaction mixture is concentrated to the above product, melting at 178 - 180 ° C.
EKSEMPEL 5EXAMPLE 5
Bis(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)ethan-1,2-disulfonat_Bis (2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium) ethane-1,2-disulfonat_
En blanding af 0,1 mol bis(2-methyl-3-hydroxy-4-hydroxymethyl-pyridyl-5-methyl)disulfid, 0,2 mol zinkstøv, 0,35 mol ethan-1,2-disulfonsyre og 200 ml vand opvarmes på dampbad i ca. 6 timer under en nitrogenatmosfære. Reaktionsblandingen afkøles, filtreres og inddampes i vacuum. Remanensen extraheres med 100 ml kogende methanol og filtreres, og filtratet afkøles til opnåelse af den ovennævnte forbindelse, der smelter ved 178 - 180° C.A mixture of 0.1 mole of bis (2-methyl-3-hydroxy-4-hydroxymethyl-pyridyl-5-methyl) disulfide, 0.2 mole of zinc dust, 0.35 mole of ethane-1,2-disulfonic acid and 200 ml of water heated on a steam bath for approx. 6 hours under a nitrogen atmosphere. The reaction mixture is cooled, filtered and evaporated in vacuo. The residue is extracted with 100 ml of boiling methanol and filtered, and the filtrate is cooled to give the above compound, which melts at 178 - 180 ° C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57605575A | 1975-05-09 | 1975-05-09 | |
US57605575 | 1975-05-09 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK179376A DK179376A (en) | 1976-11-10 |
DK143335B true DK143335B (en) | 1981-08-10 |
DK143335C DK143335C (en) | 1981-12-14 |
Family
ID=24302783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK179376A DK143335C (en) | 1975-05-09 | 1976-04-21 | ANALOGY PROCEDURE FOR PREPARING BIS (5-MERCAPTOPYRIDOXIN) -ETHAN-1,2-DISULPHONATE |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS51138684A (en) |
AR (1) | AR210883A1 (en) |
AT (1) | AT348691B (en) |
AU (1) | AU1342876A (en) |
BE (1) | BE841593A (en) |
BG (1) | BG25218A3 (en) |
CA (1) | CA1088542A (en) |
CH (1) | CH625222A5 (en) |
CS (1) | CS189003B2 (en) |
DD (1) | DD125482A5 (en) |
DE (1) | DE2620325C3 (en) |
DK (1) | DK143335C (en) |
ES (1) | ES447717A1 (en) |
FI (1) | FI61881C (en) |
FR (1) | FR2310130A1 (en) |
GB (1) | GB1490688A (en) |
GR (1) | GR59817B (en) |
HU (1) | HU172048B (en) |
IE (1) | IE43030B1 (en) |
IL (1) | IL49466A (en) |
LU (1) | LU74892A1 (en) |
NL (1) | NL7604285A (en) |
NO (1) | NO144925C (en) |
NZ (1) | NZ180691A (en) |
PL (1) | PL100306B1 (en) |
PT (1) | PT65061B (en) |
RO (1) | RO68526A (en) |
SE (1) | SE427033B (en) |
ZA (1) | ZA762750B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1695428C3 (en) * | 1967-06-08 | 1978-10-05 | Merck Patent Gmbh, 6100 Darmstadt | Derivatives of 5-mercaptopyridoxine and process for their preparation |
US3852454A (en) * | 1973-06-15 | 1974-12-03 | Merck & Co Inc | Treatment of rheumatoid arthritis |
-
1976
- 1976-04-21 SE SE7604580A patent/SE427033B/en not_active IP Right Cessation
- 1976-04-21 DK DK179376A patent/DK143335C/en not_active IP Right Cessation
- 1976-04-21 FI FI761084A patent/FI61881C/en not_active IP Right Cessation
- 1976-04-22 NO NO761367A patent/NO144925C/en unknown
- 1976-04-22 NL NL7604285A patent/NL7604285A/en not_active Application Discontinuation
- 1976-04-24 RO RO7685792A patent/RO68526A/en unknown
- 1976-04-26 CH CH521976A patent/CH625222A5/en not_active IP Right Cessation
- 1976-04-26 NZ NZ180691A patent/NZ180691A/en unknown
- 1976-04-26 IL IL49466A patent/IL49466A/en unknown
- 1976-04-27 AR AR263046A patent/AR210883A1/en active
- 1976-04-28 AU AU13428/76A patent/AU1342876A/en not_active Expired
- 1976-04-29 GR GR50620A patent/GR59817B/en unknown
- 1976-04-30 PT PT65061A patent/PT65061B/en unknown
- 1976-05-04 BG BG033100A patent/BG25218A3/en unknown
- 1976-05-04 GB GB18196/76A patent/GB1490688A/en not_active Expired
- 1976-05-04 CA CA251,741A patent/CA1088542A/en not_active Expired
- 1976-05-05 FR FR7613351A patent/FR2310130A1/en active Granted
- 1976-05-06 PL PL1976189342A patent/PL100306B1/en unknown
- 1976-05-06 LU LU74892A patent/LU74892A1/xx unknown
- 1976-05-06 DD DD192709A patent/DD125482A5/xx unknown
- 1976-05-07 IE IE990/76A patent/IE43030B1/en unknown
- 1976-05-07 ES ES447717A patent/ES447717A1/en not_active Expired
- 1976-05-07 AT AT335676A patent/AT348691B/en not_active IP Right Cessation
- 1976-05-07 DE DE2620325A patent/DE2620325C3/en not_active Expired
- 1976-05-07 ZA ZA762750A patent/ZA762750B/en unknown
- 1976-05-07 HU HU76ME00001974A patent/HU172048B/en unknown
- 1976-05-07 BE BE166849A patent/BE841593A/en unknown
- 1976-05-07 CS CS763063A patent/CS189003B2/en unknown
- 1976-05-08 JP JP51051720A patent/JPS51138684A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4261922A (en) | Process for alkoxylation of phenols | |
DK159777B (en) | N-ALKYL NORSCOPINES AND PROCEDURES FOR PREPARING THEM AND THEIR USE AS INTERMEDIATES | |
PT763017E (en) | N- (3-AMINO-2-HYDROXIBUTIL) SULFONAMIDE DERIVATIVES AS HIV PROTEASE INHIBITORS | |
WO2015085972A1 (en) | NOVEL SALTS OF 3-(2-IMIDAZO[1,2-b]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-[4-[(4-METHYL- 1-PIPERAZINYL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL] BENZAMIDE | |
DK143335B (en) | ANALOGY PROCEDURE FOR PREPARING BIS (5-MERCAPTOPYRIDOXIN) -ETHAN-1,2-DISULPHONATE | |
US4127574A (en) | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones | |
Spillane et al. | Elimination mechanisms in the anilinolysis of sulfamoyl chlorides in chloroform and acetonitrile | |
Minato et al. | Syntheses of diaza-, azaoxa-, diazaoxa-, and triazasulfonium ions | |
US2302749A (en) | Dithiocarbamates | |
Lüning et al. | Concave reagents, 8. Concave pyridines and 1, 10‐phenanthrolines with sulfonamide bridgeheads. Increased basicity by 4‐diethylamino substitution of the pyridine unit | |
US4055650A (en) | Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines | |
KR101876750B1 (en) | Novel 2-amine substituted 1,4-naphthoquinone compounds and pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient | |
Zięba et al. | 1‐Alkyl‐4‐(arylamino) quinolinium‐3‐thiolates and 7‐Alkyl‐12H‐quino [3, 4‐b]‐1, 4‐benzothiazinium Salts | |
PT1095035E (en) | Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used | |
Okamoto et al. | Reaction Mechanism in Aromatic Heterocyclic Compounds. V. Kinetics of the Reaction of 4-Nitroquinoline 1-Oxide and Related Compounds with Thioglycolic Acid. | |
Biffin et al. | Reduction by sulphoxides: The mechanism of deoxygenation of heterocyclic N-oxides and tertiary amine N-oxide | |
SU482044A3 (en) | The method of obtaining 4-or 5-nitromidazoles | |
US6303630B1 (en) | Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus | |
US2833781A (en) | Isothiourea-alkylsulfonates | |
US2654759A (en) | Derivatives of n-hydroxymethyl | |
US3291795A (en) | Hydroxylamine salts of dithiocarbamic acids | |
US2688619A (en) | Phthalimido pyrimidines and method for their production | |
Kilian et al. | Novel Condensed Thionated Bis (phosphonic) Acid Salts with a Rigid Naphthalene‐1, 8‐diyl Backbone | |
SU1467059A1 (en) | Method of producing dimethyl(2,2-dimethyl-4,6-dioxo-1,3-dioxamino-5-ilidene) dithiocarbonate | |
GB999806A (en) | New 1,2-dihydroquinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |